alexa Science Journals In Molecular Diagnosis|OMICS International|Journal Of Molecular Biomarkers And Diagnosis

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Science Journals In Molecular Diagnosis

Science Journals are multidimensional Open Access gateways for the exploration of scientific discoveries and new research in the medical and other sciences. These journals are periodical publications intended to communicate with the scientific community to further the progress of mankind. Science Journals represent the collaborative efforts of many scientists and scholars from various disciplines. Science literatures have evolved from time to time in terms of specialization and target audience. Reports of new research findings are important to fuel novel assumptions and discoveries that can only be in existence through the publication of scientific Science journals. Although some Science Journals are multidisciplinary, most journals are highly specialized and they publish articles related to specific scientific fields. In an attempt to maintain quality and ensure validity of the research being published, Science Journals subject the articles through a rigorous peer-review process, honoring copyrights. Science Journals may include various types of articles such as, letters, short communications, review articles, research articles, case reports, editorials, and other supplementary articles. The efficiency of molecular tests provides some accurate diagnoses for patients and is essential in the process of treatment and genetic counseling, and is very important for Personalized Genomic Medicine. The early and accurate diagnosis of a particular disease can improve quality of life of many patients, mainly with neurological morbidities. Our studies involve two investigative lines, including (1) the molecular diagnosis of genetic neurodegenerative diseases; (2) the role of single nucleotide polymorphisms (SNPs) in increasing the risk of neuropsychiatric diseases that affect human health, lifespan and longevity. From our genetic studies, we have detected many affected patients with autosomal dominant spinocerebellar ataxias (SCAs), a complex group of neurodegenerative diseases that share a similar molecular mechanism involving expansion of CAG repeats (dynamic mutations). Over the generations, the symptoms can start early with more severe progression, depending on the size of the CAG repeats, a phenomenon called anticipation. In addition, we have developed a non-invasive early prenatal fetal gender determination, which is important in cases with risk of transmission of X-linked diseases. Our tests involve analysis of DYS14 gene and RhD diagnosis by rapid low-cost cell-free DNA extraction with conventional and multiplex PCR that are simple, fast, inexpensive, and highly sensitive techniques.(Alexis Trott, Molecular diagnostics and personalized genomic medicine applied to neurological disorders)
 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
Last date updated on July, 2014